SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patlawche11 who wrote (46047)6/6/2018 10:55:27 AM
From: patlawche1114 Recommendations

Recommended By
captcobra1
CelebrityEquity
corndog
diaperdaddy
dorightbythem

and 9 more members

  Read Replies (3) of 63281
 
Here's a new IMMU132 Study:

Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer

clinicaltrials.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext